Dow Up 0.51% Nasdaq Up 0.24%

Intercept Pharmaceuticals, Inc. (ICPT)

-NasdaqGS
154.87 Down 1.13(0.72%) Nov 21, 4:00PM EST
Prev Close:156.00
Open:158.33
Bid:N/A
Ask:169.30 x 100
1y Target Est:443.43
Beta:-5.67
Next Earnings Date:N/A
Day's Range:154.10 - 158.70
52wk Range:50.03 - 497.00
Volume:357,868
Avg Vol (3m):477,954
Market Cap:3.31B
P/E (ttm):N/A
EPS (ttm):-12.86
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ICPTDown 0.72%3.31B
AZNUp 0.47%94.17B
SLXPUp 2.46%6.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,958.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-14.38
Quarterly EPS Est (Dec-14) :-1.65
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback